about
The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting GuidelinesBullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort studyReporting transparency: making the ethical mandate explicitVegetative pyoderma gangrenosum: a report of two new cases and a review of the literatureThe REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statementEstimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015The reporting of studies using routinely collected health data was often insufficientQuantification of risk factors for herpes zoster: population based case-control studyThe Long-Term Course of Atopic Dermatitis.Psoriasis and comorbid diseases: Implications for management.Psoriasis and comorbid diseases: Epidemiology.Call to RECORD: the need for complete reporting of research using routinely collected health data.Setting the RECORD straight: developing a guideline for the REporting of studies Conducted using Observational Routinely collected DataBetter research reporting to improve the utility of routine data for making better treatment decisions.Statin use and the risk of herpes zoster: a nested case-control study using primary care data from the U.K. Clinical Research Practice Datalink[The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement].A systematic review of randomized controlled trials of treatments for inherited forms of epidermolysis bullosa.The reporting of observational research studies in dermatology journals: a literature-based study.Risk of stroke following herpes zoster: a self-controlled case-series studyHerpes zoster risk after 21 specific cancers: population-based case-control study.Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.What causes worsening of eczema? A systematic review.Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study.Validity of The Health Improvement Network (THIN) for the study of psoriasis.Validation of treatment escalation as a definition of atopic eczema flares.Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom.Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States.Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink.The RECORD reporting guidelines: meeting the methodological and ethical demands of transparency in research using routinely-collected health dataPsoriasis and cardiovascular risk: strength in numbers, part II.A systematic review and meta-analysis of risk factors for postherpetic neuralgiaPrescription of antiviral therapy after herpes zoster in general practice: who receives therapy?What is meant by a "flare" in atopic dermatitis? A systematic review and proposal.Prevalence and treatment patterns of psoriatic arthritis in the UK.What are the best outcome measurements for atopic eczema? A systematic review.The role of furry pets in eczema: a systematic review.Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort studyIdentification of translational dermatology research priorities in the U.K.: results of an electronic Delphi exerciseChickenpox and risk of stroke: a self-controlled case series analysis.Zoster vaccination is associated with a reduction of zoster in elderly patients with chronic kidney disease
P50
Q21131774-98FCFBD3-39F9-4772-9716-79F3E8DD1641Q24654269-E2B3B90E-2F88-4C22-B803-85C7DD682EE1Q26765395-F641CD9B-41CA-491C-A15F-60710DEF8684Q28267371-BE81E278-038D-46DB-AFDB-8ACB75983D65Q28268166-4E9F06D5-4D13-480E-9D2D-1D5289DBF6D8Q28391248-7E20C46C-E6A8-4DE0-8CD8-978E643F2DB9Q28587783-8A17778D-6235-4D0F-8CFD-1831A4F196B3Q28657403-ED4EEA13-D12C-4DC9-8AA8-4739DEA92F8DQ30234105-9DEBE17A-E01C-4732-8E86-E335B3E5FD3DQ30235888-A102E951-4181-4EFA-9C38-BF831E0BFD6CQ30235889-E18B65E5-CB63-4429-893F-A3D84A9401D9Q30578669-3DB0DAC3-53DA-4518-B816-C18CBBA7293AQ30588907-43E0594B-6F5F-47CF-9E58-8C25B35AE6A3Q31050809-DD8E4E92-EAC3-40A6-9B11-0F48038F0613Q31107524-9943AF46-3F11-4CAE-93FE-ED63D5EFCC64Q31142047-BC241602-885D-490D-AB2E-6493C519EFF5Q33373138-527DA053-0118-4171-8398-133208746D30Q33579876-7F5A9DF1-E22C-4383-A8D8-420DAC62D5A4Q33598238-A1E5EE1E-BFFF-44EA-8E6D-3D22ED718B0FQ33920177-075953BA-DDA0-4853-96DC-43333DC7777BQ34371051-A3859A1E-0812-4913-A19D-141A29706363Q34557650-C681DD83-CC07-4157-A7BA-1CADDD494853Q34667717-10B1AC77-42D3-4D25-8D72-1EE85FB743B4Q34721703-A8B3F584-68BA-4EA8-90F3-932DA5BA9AE2Q35515891-08EC46C9-77EA-4CF3-A15D-23FB240AADD4Q35753936-88F8030A-7537-44D7-B31E-BFF0E3F96AA4Q35869705-EAE72C4B-BCF1-4FBA-BA69-DC0859554227Q36051506-230123E1-E85D-41A6-BA03-0A1DA2D08597Q36178861-E9372B7A-8807-4DF2-A7F7-7652C2D67CF3Q36185077-2C55CF73-E9C7-4BA2-B091-D97C240B0E09Q36389515-46875767-3CE1-4848-A8DB-8F7FC171FEF1Q36420550-DEBD8BDD-434D-4845-99C7-B3760605CF69Q36597199-F82BF1A0-143E-494B-8728-DD1271A259B7Q36612234-A706711A-E86F-4211-B4FF-DC001C18F466Q36958062-59386BA8-30EA-426F-AF05-890F0DAF8B4AQ37034821-C2DC02BC-085A-4581-B9AE-F52FB3E17547Q37063460-EEAA7A04-EF2D-4CF6-8EEE-440DFC62A82CQ37289465-FEA69EEB-92C8-42AF-9C4B-EDCDF8737221Q37395583-A753CC5F-E4E7-45C9-884A-79F77DB2C533Q37487458-70FDE9DD-843D-431A-9A71-DE691E576146
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sinead M Langan
@ast
Sinead M Langan
@en
Sinead M Langan
@es
Sinead M Langan
@nl
Sinead M Langan
@sl
type
label
Sinead M Langan
@ast
Sinead M Langan
@en
Sinead M Langan
@es
Sinead M Langan
@nl
Sinead M Langan
@sl
altLabel
Sinead Langan
@en
prefLabel
Sinead M Langan
@ast
Sinead M Langan
@en
Sinead M Langan
@es
Sinead M Langan
@nl
Sinead M Langan
@sl
P108
P106
P108
P1153
55490520500
P21
P31
P496
0000-0002-7022-7441